Regulated and prolonged expression of mIFNα in immunocompetent mice mediated by a helper-dependent adenovirus vector

Gene Therapy

Volumn 8, Issue 24, 2001, Pages 1817-1825

  Aurisicchio, L ^a   Bujard, H ^b   Hillen, W ^c   Cortese, R ^a   Ciliberto, G ^a   La Monica, N ^a   Palombo, F ^a  

^a IRBM   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Antivirals; Gene regulation; Helper dependent adenovirus vector; Tetracycline

Indexed keywords

ADENOVIRUS VECTOR; ALPHA INTERFERON; ANTIGESTAGEN; CYTOKINE; DOXYCYCLINE; MIFEPRISTONE; RAPAMYCIN; RECOMBINANT ALPHA INTERFERON; RECOMBINANT BETA INTERFERON; TETRACYCLINE; TRANSACTIVATOR PROTEIN;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; CORONAVIRUS; EXPRESSION VECTOR; GENE ACTIVATION; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; IMMUNOCOMPETENCE; INTERFERON PRODUCTION; LETHAL DOSE; LIVER INJURY; LIVER PROTECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SURVIVAL TIME; TRANSACTIVATION; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; VIRUS HEPATITIS;

ADENOVIRIDAE; ALANINE TRANSAMINASE; ANIMALS; ANTI-BACTERIAL AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE; DOXYCYCLINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; HEPATITIS, VIRAL, ANIMAL; HUMANS; INTERFERON-ALPHA; LIVER; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MODELS, ANIMAL; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSGENES;

ADENOVIRIDAE; ANIMALIA; CORONAVIRUS; DNA VIRUSES; VECTORS;

EID: 0035709608     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301596     Document Type: Article

References (30)

1. Update on adenovirus and its vectors
2. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted
3. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
4. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors: Toward realistic therapy for chronic diseases
5. Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector
6. A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signal
7. High-capacity adenoviral vectors for gene transfer and somatic gene therapy
8. Long-term doxycycline-controlled expression of human tyrosine hydroxylase after direct adenovirus-mediated gene transfer to a rat model of Parkinson’s disease
9. Adenovirus-mediated regulable target gene expression in vivo
10. Tet repressor-based system for regulated gene expression in eukaryotic cells: Principles and advances
11. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters
12. Transcriptional activation by tetracyclines in mammalian cells
13. Lentiviral vectors: Regulated gene expression
14. In vivo manipulation of interleukin-2 expression by a retroviral tetracycline (tet)-regulated system
15. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation
16. Exploring the sequence space for tetracycline-dependent transcriptional activators: Novel mutations yield expanded range and sensitivity
17. Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon
18. Liver-specific alpha 2 interferon gene expression results in protection from induced hepatitis
19. Interferon gene transfer by a hepatitis B virus vector efficiently suppresses wild-type virus infection
20. Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases
21. Optimization of the helper-dependent adenovirus system for production and potency in vivo
22. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice
23. Effect of exogenous mouse interferon on murine fulminant hepatitis induced by mouse hepatitis virus type 2
24. Protective effect of recombinant murine interferon beta against mouse hepatitis virus infection
25. Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice
26. Human adenovirus vectors for gene transfer into mammalian cells
27. Long-term regulated expression of growth hormone in mice after intramuscular gene transfer
28. Long-term, non-invasive imaging of regulated gene expression in living mice
29. Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors
30. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons